St John's wort for depression: scoping review about perceptions and use by general practitioners in clinical practice.
Kirsty ForsdikeMarie PirottaPublished in: The Journal of pharmacy and pharmacology (2017)
Consumers drive SJW use but often do not disclose to their GPs, which is concerning due to issues about safety. Pharmacists could play an important role here. Improved education about SJW is required for both GPs and consumers, including the need for communication between them and their pharmacists. Lack of adoption of evidence-based therapy for depression should be explored further.